Insulin-induced vasodilation is dependent on tetrahydrobiopterin synthesis☆
Received 1 August 1997; accepted 23 March 1998.
Abstract
Insulin has been shown to elicit vasodilation through increases in nitric oxide (NO) production. To examine whether insulin may modulate the availability of tetrahydrobiopterin (BH4) (an absolute cofactor requirement for NO synthase activation), we studied the effects of insulin (150 nmol/L) on femoral arterial reactivity (to norepinephrine [NE]) in the presence and absence of 2,4-diamino-6-hydroxypyrimidine (DAHP), a specific inhibitor of BH4 production. Our data indicate that inhibition of BH4 synthesis results in an attenuation in the vasodepressor effect of insulin. One possibility is that insulin may regulate NO production by increasing cofactor (BH4) availability for activation of NO synthase.
No full text is available. To read the body of this article, please view the PDF online.
aDivision of Pharmacology and Toxicology, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, Canada
bDepartment of Pharmacology and Therapeutics, Faculty of Medicine, The University of British Columbia, Vancouver, Canada
Address reprint requests to John H. McNeill, PhD, Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC V6T 1Z3, Canada.
☆ Supported by a grant from the Heart and Stroke Foundation of British Columbia and Yukon. S.V. is a Fellow of Medical Research Council of Canada. E.A. is a recipient of a University of British Columbia Graduate Fellowship and a Heart and Stroke Foundation of BC & Yukon Summer Studentship Award.
1 Current address for S.V.: Division of Cardiology, Foothills Hospital, Calgary, Canada.